Flavio Moroni

Flavio Moroni publications per year

Flavio Moroni publication distribution in Neuroscience in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Neuroscience in 2026. The highlighted bar marks where Flavio Moroni sits on this spectrum.

Flavio Moroni D-index placement in Neuroscience in 2026

The chart shows the D-index (discipline H-index) distribution of Neuroscience scientists ranked by Research.com in 2026. The highlighted bar marks where Flavio Moroni sits on this spectrum.

Best Publications

• Excitatory amino acid release and free radical formation may cooperate in the genesis of ischemia-induced neuronal damage

  Domenico E. Pellegrini-Giampietro;Giovanna Cherici;Marina Alesiani;Vincenzo Carla

  660
  Citations

• Adenosine decreases aspartate and glutamate release from rat hippocampal slices

  R Corradetti;G Lo Conte;F Moroni;M B Passani

  509
  Citations

• Presence of Kynurenic Acid in the Mammalian Brain

  Unknown

  309
  Citations

• Pharmacological inhibition of histone deacetylases by suberoylanilide hydroxamic acid specifically alters gene expression and reduces ischemic injury in the mouse brain.

  Giuseppe Faraco;Tristano Pancani;Laura Formentini;Paolo Mascagni

  298
  Citations

• GM1 ganglioside stimulates the regeneration of dopaminergic neurons in the central nervous system.

  G. Toffano;G. Savoini;F. Moroni;G. Lombardi

  289
  Citations

• Excitatory amino acid release from rat hippocampal slices as a consequence of free-radical formation.

  Domenico E. Pellegrini‐Giampietro;Giovanna Cherici;Marina Alesiani;Vincenzo Carlà

  288
  Citations

• Presynaptic kynurenate-sensitive receptors inhibit glutamate release

  R. Carpenedo;A. Pittaluga;A. Cozzi;S. Attucci

  284
  Citations

• High mobility group box 1 protein is released by neural cells upon different stresses and worsens ischemic neurodegeneration in vitro and in vivo

  G. Faraco;S. Fossati;M. E. Bianchi;M. Patrone

  268
  Citations

• Inhibitors of kynurenine hydroxylase and kynureninase increase cerebral formation of kynurenate and have sedative and anticonvulsant activities

  R. Carpenedo;A. Chiarugi;P. Russi;G. Lombardi

  222
  Citations

• Pharmacological Characterization of 1-Aminoindan-1,5-dicarboxylic Acid, a Potent mGluR1 Antagonist

  Flavio Moroni;Grazia Lombardi;Christian Thomsen;Patrizia Leonardi

  219
  Citations

• Kynurenic acid: a metabolite with multiple actions and multiple targets in brain and periphery

  Flavio Moroni;Andrea Cozzi;Maria Sili;Guido Mannaioni

  215
  Citations

• Poly(ADP-ribose)polymerase 1 (PARP-1) and postischemic brain damage.

  Flavio Moroni

  204
  Citations

• 1-Aminoindan-1,5-dicarboxylic acid: a novel antagonist at phospholipase C-linked metabotropic glutamate receptors.

  Roberto Pellicciari;Roberto Luneia;Gabriele Costantino;Maura Marinozzi

  198
  Citations

• The excitotoxin quinolinic acid is present and unevenly distributed in the rat brain.

  F. Moroni;G. Lombardi;V. Carlà;G. Moneti

  198
  Citations

• Modulation of the kynurenine pathway in search for new neuroprotective agents. Synthesis and preliminary evaluation of (m-nitrobenzoyl)alanine, a potent inhibitor of kynurenine-3-hydroxylase.

  Roberto Pellicciari;Benedetto Natalini;Gabriele Costantino;Mahmoud R. Mahmoud

  194
  Citations

• Nuclear Poly(ADP-ribose) Polymerase-1 Rapidly Triggers Mitochondrial Dysfunction

  Giulia Cipriani;Elena Rapizzi;Alfredo Vannacci;Rosario Rizzuto

  181
  Citations

• Activation of type 5 metabotropic glutamate receptors enhances NMDA responses in mice cortical wedges

  S Attucci;V Carlà;G Mannaioni;F Moroni

  175
  Citations

• Calcium channel inhibitors suppress the morphine-withdrawal syndrome in rats.

  F. Bongianni;V. Carla;F. Moroni;D.E. Pellegrini-Giampietro

  173
  Citations

• Protection with metabotropic glutamate 1 receptor antagonists in models of ischemic neuronal death: time-course and mechanisms

  Domenico E. Pellegrini-Giampietro;Fiamma Peruginelli;Elena Meli;Andrea Cozzi

  168
  Citations

• Kynurenine Hydroxylase Inhibitors Reduce Ischemic Brain Damage: Studies with (m-Nitrobenzoyl)-Alanine (mNBA) and 3,4-Dimethoxy-[-N-4-(Nitrophenyl)Thiazol-2YL]-Benzenesulfonamide (Ro 61-8048) in Models of Focal or Global Brain Ischemia

  Unknown

  165
  Citations